[1] MAI KT,PERKINS DG,COLLINS JP.Epithelioid cell variant of renal angiomyolipoma [J].Histopathology,1996,28(3):277-280.
[2] MONTIRONI R,CHENG L,SCARPELLI M,et al.Pathology and genetics:Tumours of the urinary system and male genital system:Clinical implications of the 4th edition of the WHO classification and beyond [J].Eur Urol,2016,70(1):120-123.
[3] HALPENNY D,SNOW A,MCNEILL G,et al.The radiological diagnosis and treatment of renal angiomyolipoma-current status [J].Clin Radiol,2010,65(2):99-108.
[4] HUANG KH,HUANG CY,CHUNG SD,et al.Malignant epithelioid angiomyolipoma of the kidney [J].J Formos Med Assoc,2007,106(2 Suppl):S51-54.
[5] TSAI CC,WU WJ,LI CC,et al.Epithelioid angiomyolipoma of the kidney mimicking renal cell carcinoma:a clinicopathologic analysis of cases and literature review [J].Kaohsiung J Med Sci,2009,25(3):133-140.
[6] AYDIN H,MAGI-GALLUZZI C,LANE BR,et al.Renal angiomyolipoma:clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association [J].Am J Surg Pathol,2009,33(2):289-297.
[7] DICKINSON M,RUCKLE H,BEAGHLER M,et al.Renal angiomyolipoma:optimal treatment based on size and symptoms [J].Clin Nephrol,1998,49(5):281-286.
[8] ZHANG J,XU XJ,CHEN ZX,et al.The value of computed tomography in the diagnostic and prognostic prediction of renal epithelioid angiomyolipoma [J].Urol J,2023,20(5):337-343.
[9] CUI L,ZHANG JG,HU XY,et al.CT imaging and histopathological features of renal epithelioid angiomyolipomas [J].Clin Radiol,2012,67(12):e77-82.
[10] KIM TM,AHN H,LEE HJ,et al.Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma:using a radiomics model combined with CT imaging characteristics [J].Abdom Radiol (NY),2022,47(8):2867-2880.
[11] LIU Y,QU F,CHENG R,et al.CT-imaging features of renal epithelioid angiomyolipoma [J].World J Surg Oncol,2015,13:280-289.
[12] LUO C,LIU Z,GAO M,et al.Renal epithelioid angiomyolipoma:computed tomography manifestation and radiologic-pathologic correlation depending on different epithelioid component percentages [J].Abdom Radiol (NY),2022,47(1):310-319.
[13] JINZAKI M,TANIMOTO A,NARIMATSU Y,et al.Angiomyolipoma:imaging findings in lesions with minimal fat [J].Radiology,1997,205(2):497-502.
[14] HAFRON J,FOGARTY JD,HOENIG DM,et al.Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations [J].Urology,2005,66(6):1155-1159.
[15] SILVERMAN SG,MORTELE KJ,TUNCALI K,et al.Hyperattenuating renal masses:etiologies,pathogenesis,and imaging evaluation [J].Radiographics,2007,27(4):1131-1143.
[16] LOW G,SAHI K,DHLIWAYO H.Low T2 signal intensity on magnetic resonance imaging:a feature of minimal fat angiomyolipomas [J].Int J Urol,2012,19(1):90-91.
[17] LEI JH,LIU LR,WEI Q,et al.A four-year follow-up study of renal epithelioid angiomyolipoma:a multi-center experience and literature review [J].Sci Rep,2015,5:10030-10034.
[18] BOUDAOUARA O,KALLEL R,DHIEB D,et al.Renal angiomyolipoma:Clinico-pathologic study of 17 cases with emphasis on the epithelioid histology and p53 gene abnormalities [J].Ann Diagn Pathol,2020,47:1-6.
[19] CALIO A,BRUNELLI M,GOBBO S,et al.Cathepsin K:A novel diagnostic and predictive biomarker for renal tumors [J].Cancers (Basel),2021,13(10):2241-2255.
[20] PEA M,BONETTI F,MARTIGNONI G,et al.Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous:the identification of malignant epithelioid angiomyolipoma [J].Am J Surg Pathol,1998,22(2):180-187.
[21] DESAI S,HEJMADI R,KRISHNAMURTHY S,et al.Renal angiomyolipoma.A clinicopathologic,immunohistochemical,and follow-up study of 46 cases [J].Am J Surg Pathol,2001,25(7):972-973.
[22] 裴媛媛,王龙,濮珍红,等.肾上皮样血管平滑肌脂肪瘤临床病理分析[J].现代肿瘤医学,2023,31(17):3266-3269.
PEI Yuanyuan,WANG Long,PU Zhenhong,et al.A clinicopathological study on renal epithelioid angiomyolipoma[J].Modern Oncology,2023,31(17):3266-3269.
[23] YANG JW,LIANG C,YANG L.Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma:A narrative review [J].Kaohsiung J Med Sci,2022,38(10):925-932.
[24] BISSLER JJ,MCCORMACK FX,YOUNG LR,et al.Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis [J].N Engl J Med,2008,358(2):140-151.
[25] KENERSON H,FOLPE AL,TAKAYAMA TK,et al.Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms [J].Hum Pathol,2007,38(9):1361-1371.
[26] SWITAJ T,SOBIBOROWICZ A,TETERYCZ P,et al.Efficacy of sirolimus treatment in PEComa-10 years of practice perspective [J].J Clin Med,2021,10(16):145-151.
[27] GUO G,GU L,ZHANG X.Everolimus in invasive malignant renal epithelioid angiomyolipoma [J].Front Oncol,2020,10:978-985.
[28] ANWAIER A,XU WH,TIAN X,et al.club suit symbol evaluation of clinicopathological profiles and development of a risk model in renal epithelioid angiomyolipoma patients:a large-scale retrospective cohort study [J].BMC Urol,2022,22(1):148-159.
[29] KAWASOE C,MIYAMOTO Y,ITO K,et al.Epithelioid angiomyolipoma with tumor thrombus into inferior vena cava presurgically treated with combination therapy of pembrolizumab and axitinib:A case report [J].Res Rep Urol,2023,15:447-452.
[30] NESE N,MARTIGNONI G,FLETCHER CD,et al.Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney:A clinicopathologic study of 41 cases:detailed assessment of morphology and risk stratification [J].Am J Surg Pathol,2011,35(2):161-176.
[31] BRIMO F,ROBINSON B,GUO C,et al.Renal epithelioid angiomyolipoma with atypia:a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy [J].Am J Surg Pathol,2010,34(5):715-722.
[32] ZHANG Y,WEI X,TENG X,et al.p53 aberration and TFE3 gene amplification may be predictors of adverse prognosis in epithelioid angiomyolipoma of the kidney [J].Diagn Pathol,2023,18(1):14-22.